AR and neoplasm: Furthermore, oral inoculation of (R)-9b also caused a reduction in pY284-ACK1, leading to the loss of pY267-AR and, hence, acK609-AR expression (Fig. 6G), providing insights regarding the probable mechanism of tumor growth inhibition upon (R)-9b treatment.